Predictors for Survival and Relapse in Patients (pts) with Diffuse Large b-Cell Lymphoma (DLBCL) Treated with Anti-CD19 CAR T-Cell Therapy: A Case for Early Intervention in High-Risks Pts Assessed By Day 30

Authors :: Issa F. Khouri
Hyunsoo Hwang
Sattva S. Neelapu
Xuemei Wang
Chitra Hosing
Sairah Ahmed
Partow Kebriaei
May Daher
Amanda L. Olson
Paolo Anderlini
Jin S. Im
Jason Westin
Elizabeth J Shpall
Richard E Champlin
Loretta J. Nastoupil
Source :: Blood. 140:7502-7503
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools